Litalir 500 mg tvrde kapsule
| Name | Litalir 500 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-923595891 |
| Active Substance | hidroksikarbamid |
| Composition | jedna tvrda kapsula sadrži 500 mg hidroksikarbamida |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Haupt Pharma Amareg GmbH, Regensburg, Njemačka Latina Pharma S.p.A., Sermoneta, Italija |
| Marketing Authorisation Holder | Cheplapharm Arzneimittel GmbH, Ziegelhof 24, Greifswald, Njemačka |
| Marketing Authorisation Date | 01.08.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/131 |
| Registration Number | 381-12-01/154-22-61 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01XX05 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
